Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained-release buprenorphine formulations

Sustained-release buprenorphine formulations

US Patent 10744132 · Granted Aug 18, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Naltrexone injectable sustained release formulation2025
Naltrexone injectable sustained release formulation2025
Ketamine pamoate and use thereof2024
Ketamine pamoate and use thereof2024
Long-acting injectable formulations and crystalline forms of buprenorphine deriv2022
Long-acting injectable formulations and crystalline forms of buprenorphine deriv2022
Long-acting injectable formulations and crystalline forms of buprenorphine deriv2022
Compositions and methods for increasing telomerase activity2018
Compositions and methods for increasing telomerase activity2016
Compositions and methods for increasing telomerase activity2013